Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew W Simonson

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|October 10, 2025
CD8+ lymphocytes in immunity against tuberculosisJiaxiang Li, Andrew W Simonson, JoAnne L Flynn
Molecules (Basel, Switzerland)|June 18, 2020
Supramolecular Peptide Assemblies as Antimicrobial ScaffoldsAndrew W Simonson, Matthew R Aronson, Scott H Medina
Cell Reports. Medicine|August 8, 2025
Host-intrinsic and host-extrinsic factors modulate immunity to Mtb infection, reinfection, and noncanonical vaccination routesJoshua D Bromley, Andrew W Simonson, Alex K Shalek, et al.
Acta Biomaterialia|September 22, 2018
Lipopeptisomes: Anticancer peptide-assembled particles for fusolytic oncotherapyMatthew R Aronson, Andrew W Simonson, Lindsey M Orchard, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|November 7, 2018
Bioresponsive peptide-polysaccharide nanogels - A versatile delivery system to augment the utility of bioactive cargoAndrew W Simonson, Atip Lawanprasert, Tyler D P Goralski, et al.
Biomaterials|April 29, 2021
Extracellular matrix-inspired inhalable aerogels for rapid clearance of pulmonary tuberculosisAndrew W Simonson, Todd M Umstead, Atip Lawanprasert, et al.
Biomacromolecules|January 26, 2022
Inhalable SARS-CoV-2 Mimetic Particles Induce Pleiotropic Antigen PresentationAtip Lawanprasert, Andrew W Simonson, Sarah E Sumner, et al.
Cellular and Molecular Bioengineering|November 13, 2020
Re-engineering Antimicrobial Peptides into Oncolytics Targeting Drug-Resistant Ovarian CancersMatthew R Aronson, Erika S Dahl, Jacob A Halle, et al.
Nature Microbiology|January 10, 2025
A BCG kill switch strain protects against Mycobacterium tuberculosis in mice and non-human primates with improved safety and immunogenicityAlexander A Smith, Hongwei Su, Joshua Wallach, et al.
Biorxiv : the Preprint Server for Biology|December 4, 2023
A "suicide" BCG strain provides enhanced immunogenicity and robust protection against <i>Mycobacterium tuberculosis</i> in macaquesAlexander A Smith, Hongwei Su, Joshua Wallach, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of Immunology (Baltimore, Md. : 1950)|October 10, 2025
CD8+ lymphocytes in immunity against tuberculosisJiaxiang Li, Andrew W Simonson, JoAnne L Flynn
Molecules (Basel, Switzerland)|June 18, 2020
Supramolecular Peptide Assemblies as Antimicrobial ScaffoldsAndrew W Simonson, Matthew R Aronson, Scott H Medina
Cell Reports. Medicine|August 8, 2025
Host-intrinsic and host-extrinsic factors modulate immunity to Mtb infection, reinfection, and noncanonical vaccination routesJoshua D Bromley, Andrew W Simonson, Alex K Shalek, et al.
Acta Biomaterialia|September 22, 2018
Lipopeptisomes: Anticancer peptide-assembled particles for fusolytic oncotherapyMatthew R Aronson, Andrew W Simonson, Lindsey M Orchard, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|November 7, 2018
Bioresponsive peptide-polysaccharide nanogels - A versatile delivery system to augment the utility of bioactive cargoAndrew W Simonson, Atip Lawanprasert, Tyler D P Goralski, et al.
Biomaterials|April 29, 2021
Extracellular matrix-inspired inhalable aerogels for rapid clearance of pulmonary tuberculosisAndrew W Simonson, Todd M Umstead, Atip Lawanprasert, et al.
Biomacromolecules|January 26, 2022
Inhalable SARS-CoV-2 Mimetic Particles Induce Pleiotropic Antigen PresentationAtip Lawanprasert, Andrew W Simonson, Sarah E Sumner, et al.
Cellular and Molecular Bioengineering|November 13, 2020
Re-engineering Antimicrobial Peptides into Oncolytics Targeting Drug-Resistant Ovarian CancersMatthew R Aronson, Erika S Dahl, Jacob A Halle, et al.
Nature Microbiology|January 10, 2025
A BCG kill switch strain protects against Mycobacterium tuberculosis in mice and non-human primates with improved safety and immunogenicityAlexander A Smith, Hongwei Su, Joshua Wallach, et al.
Biorxiv : the Preprint Server for Biology|December 4, 2023
A "suicide" BCG strain provides enhanced immunogenicity and robust protection against <i>Mycobacterium tuberculosis</i> in macaquesAlexander A Smith, Hongwei Su, Joshua Wallach, et al.
Pageof 2